Discover Innovation and Rewards at CHINT Limitless 2024 Super Brand Season

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June 1st to July 31st, 2024. This exciting campaign aims to honor electricians, installers, and panel builders worldwide, recognizing their invaluable contributions to the industry. Campaign […]

Read More »

Discover Innovation and Rewards at CHINT Limitless 2024 Super Brand Season

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June 1st to July 31st, 2024. This exciting campaign aims to honor electricians, installers, and panel builders worldwide, recognizing their invaluable contributions to the industry. Campaign […]

Read More »

Discover Innovation and Rewards at CHINT Limitless 2024 Super Brand Season

CHINT Limitless super brand season SHANGHAI, July 10, 2024 (GLOBE NEWSWIRE) — CHINT is excited to announce the global launch of its “Limitless 2024 Cool Season” campaign, running from June 1st to July 31st, 2024. This exciting campaign aims to honor electricians, installers, and panel builders worldwide, recognizing their invaluable contributions to the industry. Campaign […]

Read More »

Bombardier Positions Challenger 3500 Business Jet Mockup in Olbia, Italy, For Customer Viewings Throughout the Summer

The Bombardier Challenger 3500 aircraft mockup The Bombardier Challenger 3500 business jet mockup is presented at the Costa Smeralda Airport in Olbia, Italy, after stops in Paris and Nice Full-size mockup is on display throughout the summer at the Sardinia FBO, showcasing to clients the Challenger 3500 award-winning cabin and exclusive Nuage seat Exceptional comfort, remarkable performance, and trusted […]

Read More »

CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene Therapy for Hemophilia B in Europe

MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) — Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the first gene therapy administered as a treatment in a real-world setting for hemophilia B in Europe. […]

Read More »

Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank

REGULATED INFORMATION INSIDE INFORMATION Nyxoah Has Signed a €37.5 Million Loan Facility Agreement with the European Investment Bank Mont-Saint-Guibert, Belgium – July 3, 2024, 12:30pm CET / 6:30am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea […]

Read More »